The results showed that AKT1, TP53, TNF, VEGFA, and CASP3, the core targets, were correlated with the progression of CRF in GC and may be important in the treatment of the disease, as shown in Figure 14 and Table 5. Here, VEGFA is linked to gastric cancer.